Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis-Reference-Cited by-同舟云学术

Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis

Published:2018-11 Issue:5 Volume:268 Page:894-902
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Bhangu Jagdeep Singh,Beer Andrea,Mittlböck Martina,Tamandl Dietmar,Pulverer Walter,Schönthaler Silvia,Taghizadeh Hossein,Stremitzer Stefan,Kaczirek Klaus,Gruenberger Thomas,Gnant Michael,Bergmann Michael,Mannhalter Christine,Weinhäusel Andreas,Oehler Rudolf,Bachleitner-Hofmann Thomas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference20 articles.

1. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial;Gruenberger;Ann Oncol,2015

2. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases;Stremitzer;Ann Surg Oncol,2015

3. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer;Wang;Int J Colorectal Dis,2001

4. Methylated circulating tumor DNA in blood: power in cancer prognosis and response;Warton;Endocr Relat Cancer,2016

5. Methylation of cell-free circulating DNA in the diagnosis of cancer;Warton;Front Mol Biosci,2015

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Baseline VAF in Circulating tumor DNA and Tumor Tissues Predicting Prognosis of Patients with Colorectal Cancer Liver Metastases After Curative Resection;Clinics and Research in Hepatology and Gastroenterology;2024-09

2. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers;European Journal of Pharmacology;2024-06

3. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance;Journal of Translational Medicine;2024-05-27

4. Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer;Clinical and Translational Oncology;2024-05-22

5. Research progress and applications of epigenetic biomarkers in cancer;Frontiers in Pharmacology;2024-04-12